Semanat 8 mg/3 mL multidose vial is a prescription medicine containing semaglutide, a GLP-1 receptor agonist. It is used primarily for:
- Type 2 diabetes to improve blood sugar control.
- In some cases, weight management in eligible adults, under a doctor's supervision.
Key information
- Strength: 8 mg/3 mL multidose vial.
- Administration: Injected under the skin (subcutaneously) once a week. The 8 mg vial is typically designed to provide four 2 mg doses, but your doctor will determine the correct dose for you.
- Storage: Refrigerate at 2–8°C. Do not freeze.
- Common side effects
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Decreased appetite
- Stomach discomfort
Important precautions
- Do not start at the 2 mg weekly dose unless your doctor has already increased your dose gradually.
- Avoid use if you have a personal or family history of certain thyroid cancers or if you've had a serious allergic reaction to semaglutide.
- Inform your doctor if you have pancreatitis, gallbladder disease, kidney problems, or if you are pregnant or breastfeeding.
